What is the mechanism of action of Axitinib/Axitinib? How does it work?

Axitinib/Axitinibis a kinase inhibitor, Axitinib/Axitinib and a Velumab is used in combination with RCC for the first-line treatment of patients with advanced renal cell carcinoma (RCC). Axitinib/Axitinibis indicated as a single agent for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.

Axitinib has been shown to inhibit receptor tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, and VEGFR-3, at therapeutic plasma concentrations. These receptors have been implicated in pathological angiogenesis, tumor growth, and cancer progression. Axitinib inhibits VEGF-mediated endothelial cell proliferation and survival in vitro and in mouse models. Axitinib was shown to inhibit tumor growth and VEGFR-2 phosphorylation in a tumor xenograft mouse model.

Axitinib is a second-generation tyrosine kinase inhibitor. Its mechanism of action is as follows: selectively inhibiting vascular endothelial growth factor receptors (vascular endothelial growth factor receptor1, vascular endothelial growth factor receptor2, vascular endothelial growth factor receptor3). Through this mechanism of action, axitinib blocks angiogenesis, tumor growth, and metastasis. Overseas generic drugs are available in Bangladesh, and the retail price of Bangladeshi Beacon Pharmaceutical is about 5mg 60 tablets 1800 yuan. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.